【摘 要】
:
AIM To verify whether recurrence-free survival(RFS)surrogates overall survival(OS)in phaseⅢtrials for resectable colorectal liver metastases(CRLM).METHODS MEDL
【机 构】
:
DepartmentofUpperGastrointestinalandHepato-Pancreato-BliliarySugery,DepartmentofGastroenterology,Ins